N-methyl-D-aspartate receptor subunit GluN1 (NR1) glycine site (GluN1 glycine site)

The N-methyl-D-aspartate receptor (NMDAR) subunit GluN1 glycine site is a mandatory co-agonist binding site essential for the activation of the NMDAR ion channel. While glutamate binds to the GluN2 subunits, the GluN1 subunit must bind either glycine or D-serine to allow the channel to open upon membrane depolarization (Paoletti et al., 2013, Nature Reviews Neuroscience). This site plays a fundamental role in mediating excitatory neurotransmission and synaptic plasticity, which are the cellular underpinnings of learning and memory (Traynelis et al., 2010, Pharmacological Reviews). In pathology, NMDAR hypofunction—often linked to inadequate glycine site occupancy—is a leading hypothesis for the pathophysiology of schizophrenia, particularly regarding cognitive and negative symptoms (Coyle, 2006, Schizophrenia Bulletin). Conversely, overactivation of NMDARs can lead to excitotoxicity, contributing to neuronal death in stroke and neurodegenerative diseases. Pharmacological agents targeting this site include partial agonists like D-cycloserine, which are explored for cognitive enhancement and treating anxiety disorders, and antagonists like gavestinel, which were investigated for neuroprotection (Danysz and Parsons, 1998, Pharmacological Reviews). Because this site modulates rather than completely blocks the receptor, it is often considered a safer therapeutic target than the NMDAR pore itself.

Other names

NR1 glycine siteGlycineB siteNMDA receptor glycine binding siteGRIN1 glycine siteStrychnine-insensitive glycine siteGlycine site of the NMDA receptor

Agonists or partial agonists bind to the GluN1 subunit to facilitate NMDA receptor channel opening in the presence of glutamate, while antagonists block this site to inhibit ion flow.